Aiming for a HIV vaccine

Dr John Frater talks about his research into finding a cure for HIV. It is increasingly apparent that highly active antiretroviral therapy (HAART) may not be the long-term solution to the management of HIV infection, and that other avenues need to be explored. As a result of vari ...  Show more

Professor Tomas Hanke tells us about his research on HIV vaccine development. The enormous variations in HIV present big challenges in the development of a vaccine. Professor Tomáš Hanke focuses on the most conserved regions of the HIV-1 proteome, with the aim of developing a vac ...  Show more

HIV stellt uns auch heute noch vor große Herausforderungen in der Versorgung. Wann müssen wir an einen Test denken? Und gibt es eine Chance auf Heilung? 

For years the fight against HIV/AIDS was fought with antiretroviral drugs. But in October the Medicines Control Authority of Zimbabwe announced that it had approved the use of a new medicine against HIV/AIDS. CAB-LA is long-acting injectable cabotegravir with the aim of preventin ...  Show more

In this episode I cover HIV.

If you want to follow along with written notes on HIV go to https://zerotofinals.com/medicine/infectiousdisease/hiv/ or the infectious diseases section in the Zero to F ...

How has our knowledge of COVID-19 and how it affects people with HIV evolved? IDSA board member Max Brito, MD, FIDSA of the University of Illinois at Chicago and HIVMA board member Rachel Bender Ignacio, MD, FIDSA of the University of Washington discuss the latest COVID-19 clinic ...  Show more